Target intelligence / Profile preview

T-cell-specific surface glycoprotein CD3 (CD3)

Target
CD3
Molecular classification
Cell-surface glycoprotein, Immunoglobulin superfamily protein, Receptor-associated signaling complex, Transmembrane receptor complex
01

Overview

T-cell-specific surface glycoprotein CD3 is a multi-subunit protein complex expressed on the surface of all mature T cells and serves as both a co-receptor and signaling apparatus for the T-cell receptor (TCR). Comprised of CD3γ, CD3δ, two CD3ε, and CD3ζ chains, the complex is essential for T-cell activation: upon antigen recognition by the TCR, CD3 transduces intracellular signals via immunoreceptor tyrosine-based activation motifs (ITAMs) in its cytoplasmic tails. The CD3 complex is the main therapeutic target for monoclonal antibodies modulating T-cell activity (e.g., muromonab-CD3) and is pivotal not only in immune defense against pathogens, but also in pathological processes including cancer, autoimmunity, and transplantation. Its structural integrity, mechanism of signal transduction, and role in orchestrating immune responses have made it a major focus in immunology and drug development.

Other names
Cluster of differentiation 3CD3 complexCD3γ chainCD3δ chainCD3ε chainCD3ζ chain
02

Mechanism of action

Antibodies binding the CD3 complex block T-cell activation, resulting in immunosuppression or depletion of T cells CD3 engagement via therapeutic antibodies can induce T-cell receptor downregulation and apoptosis CD3-targeted agonists can modulate T-cell responses for various immunotherapeutic purposes

03

Biological functions

Signal transductionT-cell activationImmune responseT-cell developmentAntigen recognition (via associated T-cell receptor)
04

Disease associations

Cancer (especially in the context of immunotherapies targeting T cells)Infection (T-cell immunity is crucial for infectious disease defense)Inflammation (central in autoimmune and inflammatory diseases through T-cell activation)
05

Safety considerations

Cytokine release syndrome (CRS, especially with potent CD3 agonists and antibodies such as OKT3)Risk of infections due to immunosuppression (by depleting or inactivating T cells)Autoimmune reactions (with dysregulated or excessive T-cell activation)Anaphylactic or hypersensitivity responses (possible with monoclonal antibodies)
06

Interacting drugs

Muromonab-CD3 (OKT3, a monoclonal anti-CD3 antibody used historically in transplant rejection therapy)

2 more in the full profile.

07

Biomarkers

CD3 expression on lymphocytes (for identification of T cells in flow cytometry and tissue staining)Soluble CD3 (potential indicator of T-cell activation status in some disease contexts, though less established clinically)

Beyond the preview

Go deeper on T-cell-specific surface glycoprotein CD3 (CD3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell-specific surface glycoprotein CD3 (CD3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call